Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity

Cancer

Volumn 78, Issue 7, 1996, Pages 1374-1383

  Fan, Kathleen F M ^a,b   Hopper, Colin ^a,b   Speight, Paul M ^c   Buonaccorsi, Giovanni ^a   MacRobert, Alexander J ^a   Bown, Stephen G ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

5 aminolevulinic acid; oral cancer; oral premalignancy; photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOUTH DISEASE; MOUTH TUMOR; ORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TISSUE NECROSIS; TREATMENT OUTCOME; TUMOR BIOPSY; WOUND HEALING;

AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME;

EID: 0029835812     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961001)78:7<1374::AID-CNCR2>3.0.CO;2-L     Document Type: Article

References (33)

1. Parkin DM, Ferlay J, Pasani P. Estimates of worldwide incidence of the eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Office of Population of Censuses and Surveys. Cancer statistics registration. Series MB1 no. 21, London: HMSO, 1994.
3. Stell PM, McCormick MS. Cancer of the head and neck: are we doing any better? (letter). Lancet 1985;2:1127.
4. Axell T. Occurrence of leukoplakia and some other oral white lesion among 20,333 adult Swedish people. Community Dent Oral Epidemiol 1987;15:46-51.
5. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol 1995;79:3:321-9.
6. Maerker R, Burkhardt A. Klinik oraler Leukoplakien und Prakanzerosen: Retrospektive Studie an 200 Patienten. Dtsch Zeitschrift Mund-Kiefer-Gesichts-chirurgie 1978;2:206.
7. Speight PM, Morgan PR. The natural history and pathology of oral cancer and precancer. Community Dent Health 1993;10(suppl 1)31-41.
8. Lamey PJ. Management options in potentially malignant and malignant oral epithelial lesions. Community Dent Health 1993;10(suppl 1):53-62.
9. Scully C. Oral precancer: preventive and medical approaches to management. Eur J Cancer B Oral Oncol 1995; 31B:1:16-26.
10. Gluckman JL. Photodynamic therapy for head and neck neoplasms. Otolaryngol Clin North Am 1991;24:1559-67.
11. Pottier RH, Chow YF, LePlant J-P, Truscott TG, Kennedy JC, Beiner LA. Non invasive technique for obtaining fluorescence excitation and emission spectra in vivo. J Photochem Photobiol 1986;44S:679-87.
12. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol 1992;14:4:275-92.
13. Mustajoki P, Timonen K, Gorchein A, Seppalainen AM, Matikainen E, Tenhunen R. Sustained high plasma 5-aminoleavulinic acid concentration in a volunteer: no porphyric symptoms. Eur J Clin Invest 1992;22:6:407-11.
14. Grant WE, Hopper C, MacRobert AJ, Speight PM, Bown SG. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolevulinic acid. Lancet 1993;342:147-8.
15. Loh CS, MacRobert AJ, Bedwell J, Regula J, Krasner N, Bown SG. Oral versus intravenous administration of 5-aminolevulinic acid for photodynamic therapy. Br J Cancer 1993;68:1:41-51.
16. Regula J, MacRobert AJ, Gorchein A, Buonaccorsi GA, Thorpe SM, Spencer GM, et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumors using 5 aminolevulinic acid induced protoporphyrin IX: a pilot study. Gut 1995;36:1:67-75.
17. van der Veen N, van Leengoed H, Star W. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolevulinic acid-induced porphyrin: increased damage after multiple irradiations. Br J Cancer 1995;70:867-72.
18. Foster TH, Murant RS, Bryant RG, Knox RS, Gibson SL, Hilf R. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat Res 1991;126:3:296-303.
19. Pe MB, Ikeda H, Inokuchi T. Tumour destruction and proliferation kinetics following periodic, low power light, haematoporphyrin oligomers mediated photodynamic therapy in the mouse tongue. Eur J Cancer B Oral Oncol 1994;30B:3:174-8.
20. Messmann H, Mlkvy P, Buonaccorsi G, Davies CL, MacRobert AJ, Bown SG. Enhancement of photodynamic therapy with 5-aminolevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies. Br J Cancer 1995;72:589-94.
21. Chan W, MacRobert A, Phillips D, Hart I. Use of charged couple device for imaging of intracellular phthalocyanines. J Photochem Photobiol 1989;50:617-24.
22. Grant WE, Hopper C, Speight PM, MacRobert AJ, Bown SG. Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity. J Laryngol Otol 1993;107:12:1140-5.
23. Grant WE, Hopper C, Speight P, Bown SG. Photodynamic therapy of the oral cavity: response of normal tissue and squamous cell carcinomas. Spinelli P, Dal Fante M, Marchesini R, editors. Proceedings of the International Conference on Photodynamic Therapy and Medical Laser Application, January 24-27, Milan. International Photodynamic Association, 1992. Elsevier Science Publishers, Amsterdam.
24. Hong KH, Lippman SM, Hittleman WN, Lotan R. Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic. Clin Cancer Res 1995;1:677-86.
25. Shklar G. Modern studies and concepts of leukoplakia in the mouth. J Dermatol Surg Oncol 1981;7:996-1003.
26. Lofgren LA, Ronn A, Nouri M, Lee C, Yoo D, Steinberg B. Efficacy of intravenous-σ aminolevulinic acid photodynamic therapy on rabbit papillomas. Br J Cancer 1995; 72:857-64
27. Regula J, Ravi B, Bedwell J, MacRobert AJ, Bown SG. Photodynamic therapy using 5-aminolevulinic acid for experimental pancreatic cancer-prolonged animal survival. Br J Cancer 1994;70(2):248-54.
28. Chang S, Mac Robert A, Porter J, Bown S. Application of 1,2-diethyl-3-hydroxypyridine-4-one to enhance tissue selectivity for photodynamic therapy of the bladder. Cortese D, editor Proceedings of the 5th International Conference on Photodynamic Therapy, January 21-24, Florida. International Photodynamic Association, 1994 SPIE 2371:322-326 Washington.
29. Gibson SL, van Der Meid KR, Murant RS, Raubertas RF, Hilf R. Effects of various photoirradiation regimens on the antitumour efficacy of photodynamic therapy for R3230AC mammary carcinomas. Cancer Res 1990;50:7236-41.
30. Ris HB, Altermatt HJ, Inderbitzi R, Hess R, Nachbur B, Stewart C, et al. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer 1991;64:1116-20.
31. Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation: a follow up study of 257 patients. Cancer 1984;53:184-94.
32. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK, et al. Head and neck cancer. N Engl J Med 1993;328:184-94.
33. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol 1994;12:851-73.